Immediate Impact
3 from Science/Nature 56 standout
Citing Papers
EASL Clinical Practice Guidelines on the management of hepatitis B virus infection
2025 Standout
Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States, 2019
2024 Standout
Works of Elise Tu being referenced
Short‐Duration Pan‐Genotypic Therapy With Glecaprevir/Pibrentasvir for 6 Weeks Among People With Recent Hepatitis C Viral Infection
2019
THU-157-Shortened duration pan-genotypic therapy with glecaprevir-pibrentasvir for six weeks among people with acute and recent HCV infection
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Elise Tu | 615 | 310 | 134 | 280 | 11 | 658 | |
| Leena Puustinen | 510 | 269 | 134 | 181 | 17 | 577 | |
| Suvi Lappalainen | 754 | 396 | 98 | 351 | 19 | 790 | |
| Rita Czakó | 585 | 259 | 99 | 270 | 16 | 692 | |
| Sirpa Räsänen | 629 | 296 | 110 | 264 | 22 | 694 | |
| Nathalie Parez | 468 | 224 | 169 | 151 | 14 | 611 | |
| Hainian Yan | 600 | 351 | 122 | 251 | 13 | 681 | |
| Nora Mamaní | 492 | 193 | 128 | 199 | 23 | 575 | |
| J. Green | 547 | 209 | 101 | 214 | 7 | 593 | |
| Marion Koopmans | 550 | 159 | 60 | 257 | 11 | 626 | |
| Rungnapa Malasao | 617 | 374 | 121 | 293 | 42 | 740 |
All Works
Login with ORCID to disown or claim papers
Loading papers...